Chemical Structure : Rucaparib
CAS No.: 283173-50-2
货号: PC-42680Not For Human Use, Lab Use Only.
Rucaparib (AG014699, PF-01367338) is a potent inhibitor of PARP with Ki of 1.4 nM for PARP1 in a cell-free assay, also showing binding affinity to eight other PARP domains.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥580 | In stock | |
10 mg | ¥880 | In stock | |
50 mg | ¥1980 | In stock | |
100 mg | ¥2980 | In stock | |
250 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Rucaparib (AG014699, PF-01367338) is a potent inhibitor of PARP with Ki of 1.4 nM for PARP1 in a cell-free assay, also showing binding affinity to eight other PARP domains.
Rucaparib (AG014699, PF-01367338) inhibits PARP-1 activity by 97.1% at a concentration of 1 μM in permeabilised D283Med cells.
Rucaparib (AG014699, PF-01367338) enhances the antitumor activity of temozolomide and indicates complete and sustained tumor regression in NB1691 and SHSY5Y xenografts.
分子量 | 323.3641 | |
分子式 | C19H18FN3O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]- |
1. Thomas HD, et al. Mol Cancer Ther, 2007, 6(3), 945-956.
2. Daniel RA, et al. Clin Cancer Res, 2009, 15(4), 1241-1249.
3. Daniel RA, et al. Br J Cancer, 2010, 103(10), 1588-1596.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright